COO vs PBYI · P/E 36, rev $4.09B vs P/E 4.3, rev $56.5M
The Cooper Companies, Inc (COO) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
COO currently screens at market cap $14.92B and trailing P/E 36.1. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the COO and PBYI stock pages for the full models.
Not investment advice.